Literature DB >> 141745

Immunologic monitoring in carcinoma of the breast.

J L Weese, R K Oldham, D C Tormey, A L Barlock, A Morales, M H Cohen, W H West, R B Herberman, T C Alford, P E Shorb, N T Tsangaris, G B Cannon, J H Dean, J Djeu, J L McCoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 141745

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN： 0039-6087


× No keyword cloud information.
  4 in total

1.  Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.

Authors:  M Gereis; A P Burford-Mason; S M Watkins
Journal:  Agents Actions       Date:  1987-12

Review 2.  Serial immune function testing to predict clinical disease relapse in patients with solid tumors.

Authors:  D P Braun; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.

Authors:  A M Liberati; J G Voelkel; E C Borden; A S Coates; D L Citrin; G T Bryan
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer.

Authors:  R K Oldham; M H Gail; M A Baker; J T Forbes; W Heineman; E Hersh; E C Holmes; R E Ritts; P W Wright
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.